Home / Companies / News /  How Eli Lilly developed a covid drug in the pandemic’s long shadow

When Covid-19 struck, drug companies around the world began racing to find vaccines and treatments. One factor has gummed up their efforts: They have to work in an environment transformed by the very problem they are trying to tackle.

Post your comment

Recommended For You

Trending Stocks

Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout